Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype

Abstract

Hypoglycaemia increased resistance to cytotoxic agents, especially in tumour cells with a high dependence on glycolysis. Dual inhibition of the PI3K/mTOR pathway may be able to attenuate such hypoglycaemia-associated resistance.